Xencor, Inc Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Xencor, Inc stock issued during period, value, new issues for the quarter ending 2024-09-30 was $189.18M.
- Xencor, Inc stock issued during period, value, new issues for the quarter ending 2018-12-31 was $0.00.
- Xencor, Inc stock issued during period, value, new issues for the quarter ending 2018-09-30 was $0.00.
- Xencor, Inc stock issued during period, value, new issues for the quarter ending 2018-06-30 was -$1.00K.
- Xencor, Inc stock issued during period, value, new issues for fiscal 2024 was $189.18M.
- Xencor, Inc stock issued during period, value, new issues for fiscal 2021 was $28.92M.
- Xencor, Inc stock issued during period, value, new issues for fiscal 2018 was $245.50M, a 8677.40% increase from fiscal 2017.
- Xencor, Inc stock issued during period, value, new issues for fiscal 2017 was $2.80M, a 97.65% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $189.18M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $189.18M 10-Q · filed 2025-11-05 | |
| 2021-12-31 | $28.92M 10-K/A · filed 2025-02-24 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $245.50M 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | |
| 2018-06-30 | -$1.00K 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $245.50M 10-Q · filed 2019-11-05 | |
| 2017-12-31 | $2.80M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $119.27M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $115.20M 10-K · filed 2018-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | |
| 2015-03-31 | $115.20M 10-Q · filed 2015-05-05 | |
| 2013-12-31 | $72.51M 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |